Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...

Beckman Coulter Life Sciences and Illumina announced the launch of the Illumina TruSight Oncology 500 DNA/ RNA assay on the ...

The Beckman Coulter Access 2 Immunoassay System is widely known for its efficiency and accuracy. Thanks to its easy-to-use interface and automation, it can efficiently handle multiple tasks ...

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...

High throughput and high productivity are standard fare for every Beckman Coulter centrifuge and the Avanti JXN Series is no exception. It’s more than capable of delivering solutions for shared ...

A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost ...

His assessment took into account Danaher’s recent Analyst Day revelations which highlighted the strengths of its Diagnostic (Dx) franchise, particularly Cepheid and Beckman Coulter. Despite the ...

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...

Furthermore, Brennan was encouraged by the specific growth initiatives discussed for key players within the Dx segment like Cepheid and Beckman Coulter. Projections for Cepheid’s growth in the low ...